|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.37 CHF | +0.81% |
|
+1.14% | +10.02% |
| 05-16 | Dpa-AFX Overview: COMPANIES from 16.05.2024 - 15:15 | DP |
| 05-16 | Novartis: presents results of tender offer for MorphoSysy | CF |
Jan 11 (Reuters) - Novartis has backed away from its pursuit of Cytokinetics, the Wall Street Journal reported on Thursday, citing sources. (Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 93.37 CHF | +0.81% | +1.14% | 210B | ||
| 59.53 USD | -0.65% | -4.14% | 6.24B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +10.02% | 210B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +8.49% | 168B | |
| -0.52% | 162B |
NOVARTIS AG 
